<DOC>
	<DOCNO>NCT00209742</DOCNO>
	<brief_summary>A randomize control study conduct patient histological stage III colorectal cancer assign postoperative adjuvant therapy uracil-tegafur plus leucovorin ( UFT+LV ) , UFT+LV / UFT , UFT+LV+PSK / UFT+PSK . The usefulness three regimen evaluate compare disease-free survival rate , overall survival rate , incidence severity adverse event , quality life .</brief_summary>
	<brief_title>Randomized Phase III Adjuvant Study Stage III Colorectal Cancer</brief_title>
	<detailed_description>A multicenter randomize open-label control study conduct patient histological stage III curability A B colorectal cancer [ accord General Rules Clinical Pathological Studies Cancer Colon , Rectum Anus , 6th edition ( Japanese Classification Colorectal Cancer , English edition ) , also accord pTNM classification facilitate overseas publication ] give postoperative oral therapy tegafur-uracil plus leucovorin ( UFT+LV ) ( 5 course ) , UFT+LV ( 5 course ) / UFT ( 1 year ) , UFT+LV+PSK ( 5 course ) / UFT+PSK ( 1 year ) . The usefulness three regimen postoperative adjuvant therapy evaluate compare disease-free survival rate ( DFR ) , overall survival rate ( OS ) , incidence severity adverse event , quality life ( QOL ) .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Krestin</mesh_term>
	<criteria>1 . Patients primary colonic carcinoma rectal carcinoma histological stage III , undergone histological curability A B surgeries 2 . Patients evaluate histologically lymph node metastasis positive 3 . Patients age 20 80 year , inclusive , time acquisition inform consent 4 . Patients performance status 0 2 5 . Patients receive preoperative cancer therapy ( radiotherapy , chemotherapy immunotherapy ) 6 . Gastrointestinal function : Patients diarrhea ( watery stool ) 7 . Patients without severe impairment renal , hepatic bone marrow function 8 . Patients serious concurrent complication ( infection ) 9 . Patients give write informed consent participate study 1 . Patients grade curability C 2 . Patients stenosis capable oral intake 3 . Among disease stage IIIa case , si/n ( ) ai/n ( ) 4 . Patients fresh hemorrhage gastrointestinal tract 5 . Patients retention body fluid necessitating treatment 6 . Patients infection , intestinal palsy intestinal occlusion 7 . Patients low end tumor involve peritoneal reflection 8 . Patients low rectal cancer ( Rb ) , involve anal canal ( P ) perianal skin ( E ) 9 . Patients active multiple cancer ; even multiple cancer metachronous , diseasefree period le 5 year ( exclude cancer situ skin cancer ) 10 . Patients pregnant hope become pregnant study period 11 . Patients poorly control diabetes treat continuous use insulin 12 . Patients history ischemic heart disease 13 . Patients concurrent psychiatric disease psychotic symptom , judge difficulty participate study 14 . Patients receive continuous administration steroid 15 . Patients experience serious drug allergy past 16 . Others , patient judge investigator subinvestigator inappropriate subject</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Colorectal Cancer , UFT , LV , Krestin , adjuvant therapy , phase III</keyword>
</DOC>